The Majority of Americans Want Dispensaries to Remain Open Despite COVID-19

A survey conducted by YouGov found that the majority of Americans believe that cannabis dispensaries should remain opening during the COVID-19 crisis, as they are an "essential business".

An online survey of more than 5,400 US citizens has found that the majority believe that cannabis dispensaries are an "essential business" and should remain open during the COVID-19 pandemic.

The study was conducted by YouGov earlier this week, in response to the growing concern about the increase in state-ordered shutdowns.

According to the survey, 53% US adults survey believe that dispensaries should remain open, while only 26% thought they should be forced to shut down.

It shows that a lot of people think cannabis is just another consumer good, like beer or wine. It's [edibles] probably the easiest way to get high without touching your face very much. Headset Director of Analytics, Liz Connors 

The remaining 21% were undecided on the issue, which drew stronger support from self-identified Democrats and non-mainstream voters. Only 43% of Republicans were in favour of keeping dispensaries open, compared to 62% and 52% for Democrats and political independents, respectively.  

Meanwhile, a majority of respondents across all age groups—except those who are 55 and older—said that they believe dispensaries should remain open during the coronavirus quarantine.

Unfortunately, while dispensaries will be allowed to remain open in the majority of states, the arrival of COVID-19 has served to significantly derail broader legalization efforts throughout the US.

The world has been in a panic ever since the new Chinese coronavirus disease—which is now officially known as COVID-19—began stoking fears of a global pandemic in early 2020.

Earlier this week New York's state government announced that its plans to introduce recreational adult-use cannabis would be indefinitely put on hold, and a campaign to legalize medicinal marijuana in Nebraska had to temporarily suspend its activities due to warnings from health officials.  

Efforts to amend California's cannabis program—while also legalizing psilocybin mushrooms—have similarly been halted, while activists in Washington D.C. lodged an application to allow for "alternative signature collection" for the campaign to decriminalise a broad variety of psychedelics.

Drug reform campaigners in Oregon have also had to cease signature collection activities amid increasing harshly lockdown orders.


This pot stock could reach new heights in 2020 due to Coronavirus

The COVID-19 pandemic is showing no signs of slowing down, and as global markets enter meltdown many cannabis companies are feeling the effects of capital crunch.

While the market crash will continue for some time, it represents a golden opportunity for investors who are capable of riding out the volatility until share prices rally.

Luckily, one pot stock has developed antimicrobial drug that can already treat two superbugs while limiting their ability to develop antibiotic resistance.

Investors can also start picking up shares at rock bottom prices, as global investor sentiment continues to dampen thanks to COVID-19.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Hugo Gray
Hugo Gray

Hugo Gray is a Melbourne-based journalist with a body of work that covers a diverse range of topics, including immigration law, sex technology, and now the rapidly expanding cannabis industry.

Leave a Reply

Your email address will not be published. Required fields are marked *